| Antidiabetic effect of brain‐derived neurotrophic factor and its association with inflammation in type 2 diabetes mellitus C Eyileten, A Kaplon-Cieslicka, D Mirowska-Guzel, L Malek, M Postula Journal of diabetes research 2017 (1), 2823671, 2017 | 220 | 2017 |
| MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis C Eyileten, Z Wicik, S De Rosa, D Mirowska-Guzel, A Soplinska, C Indolfi, ... Cells 7 (12), 249, 2018 | 173 | 2018 |
| Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review J Pordzik, D Jakubik, J Jarosz-Popek, Z Wicik, C Eyileten, S De Rosa, ... Cardiovascular diabetology 18, 1-19, 2019 | 151 | 2019 |
| The relation of the brain-derived neurotrophic factor with microRNAs in neurodegenerative diseases and ischemic stroke C Eyileten, L Sharif, Z Wicik, D Jakubik, J Jarosz-Popek, A Soplinska, ... Molecular neurobiology 58 (1), 329-347, 2021 | 139 | 2021 |
| The potential role of platelet-related microRNAs in the development of cardiovascular events in high-risk populations, including diabetic patients: a review J Pordzik, K Pisarz, S De Rosa, AD Jones, C Eyileten, C Indolfi, L Malek, ... Frontiers in endocrinology 9, 74, 2018 | 111 | 2018 |
| ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factors Z Wicik, C Eyileten, D Jakubik, SN Simões, DC Martins Jr, R Pavão, ... Journal of clinical medicine 9 (11), 3743, 2020 | 95 | 2020 |
| MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics D Jakubik, A Fitas, C Eyileten, J Jarosz-Popek, A Nowak, P Czajka, ... Cardiovascular diabetology 20, 1-29, 2021 | 85 | 2021 |
| Early biomarkers of neurodegenerative and neurovascular disorders in diabetes A Gasecka, D Siwik, M Gajewska, MJ Jaguszewski, T Mazurek, KJ Filipiak, ... Journal of Clinical Medicine 9 (9), 2807, 2020 | 73 | 2020 |
| Efficacy of hemostatic powders in upper gastrointestinal bleeding: A systematic review and meta-analysis A Facciorusso, MS Takahashi, CE Postula, VR Buccino, N Muscatiello Digestive and Liver Disease 51 (12), 1633-1640, 2019 | 67 | 2019 |
| Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel A Gasecka, R Nieuwland, M Budnik, F Dignat‐George, C Eyileten, ... Journal of thrombosis and haemostasis 18 (3), 609-623, 2020 | 59 | 2020 |
| Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome GM Gager, B Biesinger, F Hofer, MP Winter, C Hengstenberg, B Jilma, ... Vascular Pharmacology 135, 106806, 2020 | 54 | 2020 |
| Effects of SGLT2 inhibitors on ion homeostasis and oxidative stress associated mechanisms in heart failure GM Gager, D von Lewinski, H Sourij, B Jilma, C Eyileten, K Filipiak, ... Biomedicine & Pharmacotherapy 143, 112169, 2021 | 52 | 2021 |
| Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis GM Gager, G Gelbenegger, B Jilma, D Von Lewinski, H Sourij, C Eyileten, ... Frontiers in cardiovascular medicine 8, 691907, 2021 | 45 | 2021 |
| MicroRNA as potential biomarkers of platelet function on antiplatelet therapy: a review P Czajka, A Fitas, D Jakubik, C Eyileten, A Gasecka, Z Wicik, ... Frontiers in physiology 12, 652579, 2021 | 43 | 2021 |
| Long non-coding RNAs as promising therapeutic approach in ischemic stroke: a comprehensive review M Wolska, J Jarosz-Popek, E Junger, Z Wicik, T Porshoor, L Sharif, ... Molecular Neurobiology 58, 1664-1682, 2021 | 42 | 2021 |
| Stratified approaches to antiplatelet therapies based on platelet reactivity testing M Ostrowska, J Kubica, P Adamski, A Kubica, C Eyileten, M Postula, ... Frontiers in cardiovascular medicine 6, 176, 2019 | 40 | 2019 |
| Non-vitamin K oral anticoagulants (NOAC) versus vitamin K antagonists (VKA) for atrial fibrillation with elective or urgent percutaneous coronary intervention: a meta-analysis … C Eyileten, M Postula, D Jakubik, A Toma, D Mirowska-Guzel, G Patti, ... Journal of clinical medicine 9 (4), 1120, 2020 | 36 | 2020 |
| Immune cells in cancer therapy and drug delivery C Eyileten, K Majchrzak, Z Pilch, K Tonecka, J Mucha, B Taciak, ... Mediators of inflammation 2016 (1), 5230219, 2016 | 36 | 2016 |
| MicroRNAs as biomarkers of systemic changes in response to endurance exercise—a comprehensive review A Soplinska, L Zareba, Z Wicik, C Eyileten, D Jakubik, JM Siller-Matula, ... Diagnostics 10 (10), 813, 2020 | 35 | 2020 |
| Role of P2Y receptors in platelet extracellular vesicle release A Gąsecka, S Rogula, C Eyileten, M Postuła, MJ Jaguszewski, J Kochman, ... International journal of molecular sciences 21 (17), 6065, 2020 | 33 | 2020 |